Skip to content
healthcare.dev

Spleenex V

NDC 44911-0539, Aralia Quinquefolia, Potassium Gluconate, Ginkgo Biloba, Magnesium Gluconicum Dihydricum, Pancreas Suis, Spleen (Suis), Stomach (Suis), Germanium Sesquioxide, Cuprum Metallicum, Zincum Metallicum, Alpha-Ketoglutaricum Acidum, Citricum Acidum, Fumaricum Acidum, Magnesia Phosphorica, Malicum Acidum, Pyruvic Acid, Succinicum Acidum, Naphthochinonum, Aconiticum Acidum, Cis-, Natrum Oxalaceticum, liquid, from Energique, Inc..

Product NDC
44911-0539
Status
Listed
Labeler
Energique, Inc.
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0539 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMERICAN GINSENG3 [hp_X]/mL
  • POTASSIUM GLUCONATE3 [hp_X]/mL
  • GINKGO6 [hp_X]/mL
  • MAGNESIUM GLUCONATE6 [hp_X]/mL
  • SUS SCROFA PANCREAS6 [hp_X]/mL
  • SUS SCROFA SPLEEN6 [hp_X]/mL
  • SUS SCROFA STOMACH6 [hp_X]/mL
  • GERMANIUM SESQUIOXIDE8 [hp_X]/mL
  • COPPER8 [hp_X]/mL
  • ZINC8 [hp_X]/mL
  • OXOGLURIC ACID8 [hp_X]/mL
  • ANHYDROUS CITRIC ACID8 [hp_X]/mL
  • FUMARIC ACID8 [hp_X]/mL
  • MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE8 [hp_X]/mL
  • MALIC ACID8 [hp_X]/mL
  • PYRUVIC ACID8 [hp_X]/mL
  • SUCCINIC ACID8 [hp_X]/mL
  • NAPHTHOQUINE9 [hp_X]/mL
  • ACONITIC ACID, (Z)-12 [hp_X]/mL
  • SODIUM DIETHYL OXALACETATE12 [hp_X]/mL

Pharmacologic classes

Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Calculi Dissolution Agent [EPC]; Calculi Dissolution Agent [EPC]; Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Coagulation Factor Activity [PE]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibit Ovum Fertilization [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
44911-0539-14491105390130 mL in 1 BOTTLE, DROPPER (44911-0539-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 44911-0539 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0539 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 44911-0539. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.